Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Comprehensive Cancer Centers of the Desert
Palm Springs, California, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States
- Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
- U.S. Oncology Research Inc.
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2000
- Primary completion
- 31 Aug 2002
- Completion
- 31 Aug 2002
- Last update posted
- 13 Jan 2017
- Registered enrollment
- —
- Registry id
- NCT00005886
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.